No Data
Grifols Set for Strong FY24 Results as Plasma Market Recovers, Barclays Says
Tariffs Expected to Bring Pharmaceutical Price Bumps, Shortages -- Market Talk
Blood Plasma Derivatives Market Insights and Forecast 2025-2030 - Grifols, SK Plasma, and Fusion Health Care Lead the Competition
Barclays Sees Upside Share Potential for Grifols Despite Price Target Cut Amid Headline Risks
European Equities Traded in the US as American Depositary Receipts Rise Thursday
Grifols Falls as Spanish Regulator Mulls Sanctions Against Directors